http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107118295-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F222-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-06 |
| filingDate | 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107118295-B |
| titleOfInvention | A kind of polymer nanocomposite gel, preparation method and applications |
| abstract | The invention belongs to technical field of polymer materials, and in particular to a kind of polymer nanocomposite gel, preparation method and applications.For the present invention with the N containing two selenium keys, bis- (acryloyl) selenocystamines of N '-are crosslinking agent, the polymer nanocomposite gel that oxidable/reduction double-response degradation has been prepared by distilling precipitation polymerization method.This method is easy to operate, reaction condition is mild, the polymer nanocomposite gel of two selenium keys crosslinking can be obtained using traditional free radical polymerization.It is good that polymer nanocomposite gel uniform particle diameter, regular appearance, colloidal stability is prepared, can degradable be short linear molecule in the presence of reducing agent or oxidant；The release that is precisely controlled of drug can be realized when as carrier, and there is good biocompatibility, be a kind of ideal medicine controlled release carrier. |
| priorityDate | 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.